Barnabas Desta

832 total citations
29 papers, 545 citations indexed

About

Barnabas Desta is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Barnabas Desta has authored 29 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 12 papers in Immunology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Barnabas Desta's work include Systemic Lupus Erythematosus Research (22 papers), Atherosclerosis and Cardiovascular Diseases (10 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). Barnabas Desta is often cited by papers focused on Systemic Lupus Erythematosus Research (22 papers), Atherosclerosis and Cardiovascular Diseases (10 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). Barnabas Desta collaborates with scholars based in United States, United Kingdom and Sweden. Barnabas Desta's co-authors include Edward R. Hammond, Xia Wang, Chantal M. Boulanger, Henk Nab, Julia Langham, Sue Langham, J. Longmore, Addison A. Taylor, Lindsay Nicholson and Nick Pooley and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Barnabas Desta

26 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barnabas Desta United States	15	341	203	130	95	87	29	545
S. Vagnani Italy	10	356 1.0×	169 0.8×	142 1.1×	18 0.2×	36 0.4×	13	554
Joy Feld Israel	17	663 1.9×	531 2.6×	67 0.5×	38 0.4×	24 0.3×	42	854
Ritva Peltomaa Finland	13	345 1.0×	93 0.5×	54 0.4×	13 0.1×	33 0.4×	27	571
Vera Golder Australia	14	437 1.3×	239 1.2×	77 0.6×	22 0.2×	10 0.1×	24	516
Ajay Ajmani United States	13	129 0.4×	138 0.7×	106 0.8×	13 0.1×	30 0.3×	29	523
Tarek Carlos Salman-Monte Spain	10	262 0.8×	95 0.5×	83 0.6×	23 0.2×	17 0.2×	49	337
Smadar Gertel Israel	10	173 0.5×	166 0.8×	37 0.3×	16 0.2×	28 0.3×	27	423
Francesca Trentin Italy	11	247 0.7×	152 0.7×	58 0.4×	17 0.2×	13 0.1×	23	362
David Weidensaul United States	7	265 0.8×	73 0.4×	66 0.5×	37 0.4×	16 0.2×	8	359
Loes Linsen Belgium	13	71 0.2×	245 1.2×	73 0.6×	45 0.5×	56 0.6×	27	568

Countries citing papers authored by Barnabas Desta

Since Specialization

Citations

This map shows the geographic impact of Barnabas Desta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barnabas Desta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barnabas Desta more than expected).

Fields of papers citing papers by Barnabas Desta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barnabas Desta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barnabas Desta. The network helps show where Barnabas Desta may publish in the future.

Co-authorship network of co-authors of Barnabas Desta

This figure shows the co-authorship network connecting the top 25 collaborators of Barnabas Desta. A scholar is included among the top collaborators of Barnabas Desta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barnabas Desta. Barnabas Desta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aringer, Martin, Laurent Arnaud, Richard Furie, et al.. (2025). Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS). Lupus Science & Medicine. 12(1). e001336–e001336.

Ding, Bo, et al.. (2024). The Impact of Systemic Lupus Erythematosus Flares on Clinical and Economic Outcomes: The CHAMOMILE Claims Database Study in Germany. Rheumatology and Therapy. 11(2). 285–299.

Arnaud, Laurent, Richard Furie, Eric F. Morand, et al.. (2023). Burden of systemic lupus erythematosus in clinical practice: baseline data from the SLE Prospective Observational Cohort Study (SPOCS) by interferon gene signature. Lupus Science & Medicine. 10(2). e001032–e001032. 8 indexed citations

Bruce, Ian N, Sarowar Golam, Evelyn Worthington, et al.. (2022). Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus. Journal of Comparative Effectiveness Research. 11(10). 765–777. 15 indexed citations

Lin, Dora H., Irene B. Murimi, Hong Kan, et al.. (2022). Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review. Lupus. 31(7). 773–807. 6 indexed citations

Schwarting, Andreas, Marc Pignot, Xia Wang, et al.. (2021). The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization. Rheumatology and Therapy. 8(1). 375–393. 31 indexed citations

Jiang, Miao, Aimee M. Near, Barnabas Desta, Xia Wang, & Edward R. Hammond. (2021). Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004–2015. Lupus Science & Medicine. 8(1). e000503–e000503. 15 indexed citations

Samnaliev, Mihail, Sharada Weir, Julia Langham, et al.. (2021). Health-care utilization and costs in adults with systemic lupus erythematosus in the United Kingdom: a real-world observational retrospective cohort analysis. Rheumatology Advances in Practice. 5(3). rkab071–rkab071. 13 indexed citations

Hammond, Edward R., Barnabas Desta, Aimee M. Near, Xia Wang, & Miao Jiang. (2021). Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004–2015. Lupus Science & Medicine. 8(1). e000504–e000504. 24 indexed citations

10.

Clarke, Ann E., Nick Pooley, Julia Langham, et al.. (2021). Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis. Seminars in Arthritis and Rheumatism. 51(6). 1230–1241. 46 indexed citations

11.

Murimi, Irene B., Dora H. Lin, Henk Nab, et al.. (2020). Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis. BMJ Open. 10(5). e031850–e031850. 63 indexed citations

12.

Vaughan, Timothy E., et al.. (2020). Characteristics and Symptom Severity of Patients Reporting Systemic Lupus Erythematosus in the PatientsLikeMe Online Health Community: A Retrospective Observational Study. Rheumatology and Therapy. 7(1). 201–213. 16 indexed citations

13.

Pego‐Reigosa, José María, Lindsay Nicholson, Nick Pooley, et al.. (2020). The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis. Lara D. Veeken. 60(1). 60–72. 58 indexed citations

14.

Murimi, Irene B., Dora H. Lin, Hong Kan, et al.. (2020). Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States. The Journal of Rheumatology. 48(3). 385–393. 38 indexed citations

15.

Hammond, Edward R., Raj Tummala, Anna Berglind, et al.. (2020). Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signature. BMJ Open. 10(9). e036563–e036563. 8 indexed citations

16.

Hammond, Edward R., H. Kan, Jonothan C. Tierce, et al.. (2017). SAT0227 Health care utilization and costs of systemic lupus erythematosus (SLE) in the united states: systematic review. Annals of the Rheumatic Diseases. 76. 859–860. 4 indexed citations

17.

Longmore, J., Chantal M. Boulanger, Brown Mj, et al.. (1997). Comparison of the vasoconstrictor properties of the 5-HT1D-receptor agonists rizatriptan (MK-462) and sumatriptan in human isolated coronary artery: outcome of two independent studies using different experimental protocols.. PubMed. 12(1). 3–9. 34 indexed citations

18.

Desta, Barnabas, Daniel Schultz, Denis Ravel, et al.. (1996). Acute and chronic effects of dexfenfluramine on the porcine coronary artery.. Journal of Pharmacology and Experimental Therapeutics. 279(3). 1077–1085. 1 indexed citations

19.

Desta, Barnabas, M Nakashima, Michael Kirchengast, Pmgr Vanhoutte, & Chantal M. Boulanger. (1995). Previous exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor trandolaprilat in isolated canine coronary arteries.. Journal of Pharmacology and Experimental Therapeutics. 272(2). 885–891. 11 indexed citations

20.

Boulanger, Chantal M., et al.. (1994). Chronic Treatment with the CA²⁺Channel Inhibitor RO 40-5967 Potentiates Endothelium-Dependent Relaxations in the Aorta of the Hypertensive Salt Sensitive Dahl Rat. Blood Pressure. 3(3). 193–196. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact